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Abstract
Background: Postoperative pain associated with removal of mandibular third molars has been documented from 
moderate to severe during the first 24 hours after surgery, with pain peaking between 6 and 8 hours when a con-
ventional local anesthetic is used. Dental pain is largely inflammatory, and evidence-based medicine has shown 
that nonsteroidal anti-inflammatory drugs are the best analgesics for dental pain. The aim of this study was to 
compare the analgesic, anti-inflammatory and anti-trismus effect of a single dose of diclofenac and meloxicam 
after mandibular third molar extraction. 
Material and Methods: A total of 36 patients were randomized into two treatment groups, each with 18 patients, 
using a series of random numbers: Group A, was administered 100 mg of diclofenac; and Group B, 15 mg of mel-
oxicam. Drugs were administered orally 1 hour prior to surgery. We evaluated pain intensity, analgesic consump-
tion, swelling, as well as trismus. 
Results: The results of this study showed that patients receiving 15 mg of meloxicam had less postoperative pain 
(P=0.04) and better aperture than those receiving 100 mg of diclofenac (P=0.03). The meloxicam group presented 
less swelling than diclofenac group; however, significant statistical differences were not observed. 
Conclusions: Data of this double-blind, randomized, parallel-group clinical trial demonstrated that patients re-
ceiving 15 mg of preoperative meloxicam had a better postoperative analgesia and anti-trismus effect compared 
with who were given 100 mg of diclofenac after third molar extractions.
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Introduction
In the majority of cases, removal of third molars will 
lead to a significant degree of tissue trauma, causing an 
inflammatory reaction. The patient develops the com-
mon postoperative symptoms and signs of pain, facial 
swelling, dysfunction, and limited mouth opening (tris-
mus). The pain is typically brief and will peak in inten-
sity in the early postoperative period. Facial swelling 
and trismus will reach their characteristic maximum 48 
to 72 h after surgery (1).
Evidence-based medicine has shown that Non-steroidal 
anti-inflammatory drugs (NSAID) comprise the best 
analgesic for dental pain (2). The effects of NSAID are 
the result of inhibiting Cyclo-oxygenase (COX) en-
zymes, which catalyze the conversion of arachidonic 
acid into prostaglandins, which are fatty acids involved 
in the generation of pain, inflammation, and fever (3). 
Diclofenac is a commonly prescribed NSAID with an-
algesic, anti-inflammatory, and anti-pyretic properties 
that has been widely used in pain control with good 
effectiveness after third molar surgery (4,5). However, 
traditional NSAID such as diclofenac - have been wide-
ly used to treat pain, but their long term use is limited 
by serious gastrointestinal side effects (6). A meta-anal-
ysis clearly showed that high-doses of diclofenac (75 mg 
twice daily) entails similar vascular risks to the aver-
age coxib regimen studied. Absolute excess risks were 
small but serious: compared with placebo, allocation to 
a coxib or to diclofenac caused around three additional 
major vascular events per 1,000 participants annually, 
with one such event causing death (6,7). Meloxicam is 
a NSAID of the Oxicam class with selectivity toward 
COX-2 compared with COX-1. It is widely used in the 
treatment of osteoarthritis, rheumatoid arthritis, anky-
losing spondylitis, and other rheumatological conditions 
(8). In oral surgery, there are few studies concerning the 
use of meloxicam (8-14). 
The aim of this pilot study was to compare the analge-
sic, anti-inflammatory and anti-trismus effect of a sin-
gle dose of diclofenac and meloxicam after mandibular 
third molar extraction.
Material and Methods
- Design
This study was designed as a double-blind, randomized, 
parallel-group clinical trial, and was conducted in ac-
cordance with the Declaration of Helsinki. The Ethics 
Committee approved the study design. All of the sub-
jects were informed of possible risks of oral surgery and 
experimental treatments, and they signed an institution-
ally approved consent form. 
- Selection criteria
Inclusion criteria were age 18-30 years, either sex, free 
of systemic disease, clinical and radiographic diagnosis 
of a mandibular impacted third molar with no pain asso-
ciated up to the day of the surgery, and difficulty of ex-
traction (grade II, III, or IV). Exclusion criteria included 
use of analgesics 1 week before the procedure, gastritis, 
peptic ulcer, pregnancy or lactation, and known hyper-
sensitivity to the medications used.
- Randomization and blinding 
A total of 36 patients from the Department of Maxil-
lofacial Surgery of the School of Dentistry at Cuauhté-
moc University, San Luis Potosí, México, were recruit-
ed. The patients were randomized into two treatment 
groups, each with 18 patients, using a series of ran-
dom numbers: Group A, was administered 100 mg of 
diclofenac; and Group B, 15 mg of meloxicam. Drugs 
were administered orally 1 hour prior to surgery. The 
algorithm is shown in (Fig. 1). Moreover, both patients 
and an independent evaluator were blinded regarding 
the treatment administered.
- Interventions
After the administration of the assigned treatment, the 
tooth was removed. All of the surgical procedures were 
carried out at the Department of Oral and Maxillofacial 
Surgery by the same surgeon. Anesthesia was through 
block of the lingual, buccal, and inferior alveolar nerves 
using two 1.8-mL capsules of 2% lidocaine-containing 
1:100,000 epinephrine. Once anesthesia was adminis-
tered, surgery was started. A mucoperiosteal flap was 
prepared by making a distal incision to the mandibular 
second molar along the anterior edge of the ascending 
ramus of the mandible. This flap was utilized to close 
the surgical wound. Suturing was done with 4-0 silk, 
and the number of sutures was documented. Difficulty 
of extraction was based on a modified Parant scale as 
follows: Grade I, extraction with forceps and elevators; 
Grade II, extraction by osteotomy; Grade III, extrac-
tion by osteotomy and coronal section; and Grade IV, 
extraction by osteotomy, root, and coronal section (13). 
In all cases, the duration of the surgical procedure (from 
incision to final suture) was recorded. In each patient, a 
partial impacted mandibular third molar was extracted. 
- Assessment
The patients were administered 500 mg acetaminophen 
tablets and were instructed to take one or two pills for 
postsurgical medication at least 6 hours apart, accord-
ing to their requirements. Time of first rescue analgesic 
medication, i.e., time from the end of surgery until first 
intake of acetaminophen necessary for the patient, was 
registered. At the end of the evaluation period (24 hours), 
the patients returned the unused tablets. The pills were 
counted to determine the number of pills consumed. Pa-
tients having no pain relief 30 min after taking 2 aceta-
minophen tablets orally were given a 30 mg tablet of 
sublingual ketorolac as rescue analgesic procedure due 
to therapeutic failure. Total analgesic consumption (oral 
acetaminophen and sublingual ketorolac) was evalu-
ated.
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A 10 cm Visual Analog Scale (VAS) was employed 
to assess pain. The VAS consisted of an interval scale 
ranging from 0, representing no pain or discomfort, to 
10, representing maximal pain or discomfort. The VAS 
report was recorded each hour for 12 hours after com-
pletion of surgery, and the last evaluation was conduct-
ed at 24 hours. 
Facial swelling was evaluated by the method used by 
Ustun et al., (2003) (15). Distances between angle of 
the mandible and four different anatomical facial points 
(soft-tissue pogonion, outer corner of mouth, and lateral 
corner of eye and tragus) were assessed. In the same 
manner, distances of tragus to three anatomical facial 
points (soft-tissue pogonion, outer corner of mouth, 
lateral corner of eye) were evaluated. Trismus was as-
sessed by measuring the maximal aperture. Both facial 
swelling and trismus were evaluated preoperatively and 
at 6, 24, 48, and 72 hours, and a final evaluation was 
performed on day 7. Intra- and post-operative complica-
tions as well as adverse events were recorded. 
A standardized independent evaluator measured these 
parameters (pain, facial swelling, and trismus) at each 
time point.
- Statistical methods
Data were expressed as mean and Standard Deviation, 
medians and ranges, or frequencies. For numerical vari-
ables with normal distribution, the Student t test was 
used, while for numerical variables without normal dis-
tribution and ordinal variables, the Mann-Whitney U 
test was utilized. For categorical variables, the Fisher 
exact test was employed. A p value <0.05 was consid-
ered a significant statistical difference.
Results
A total of 36 patients were enrolled in the study, and all 
patients were included in the statistical analysis. There 
were no statistically significant differences between 
the study groups with regard to the number of patients 
included and their age distribution, sex, height, and 
weight. Surgical variables that could have influenced 
postoperative pain intensity were considered homoge-
neous between the groups, including length and diffi-
culty of the surgical procedure (Table 1).
Time of first rescue analgesic medication, the number 
of patients taking acetaminophen at 3, 6, 9, 12 and 24 
hours, analgesic consumption, and the number of pa-
tients requiring rescue analgesic procedure with sublin-
gual ketorolac due to therapeutic failure was similar in 
the two treatment groups (Table 2). 
Pain levels assessed by the VAS had their peaks at fifth 
hour postoperative and then began to decrease. Meloxi-
cam was only better than diclofenac at fifth hour post-
operative according to VAS scores (P=0.04), (Fig. 2). 
As mentioned previously, seven facial anatomical dis-
tances, measured pre- and post-surgery, were employed 
to determine facial swelling and the possible anti-in-
flammatory effects of the medications tested. However; 
no statistical differences were observed (Table 3). 
In both treatment groups, aperture before surgery was 
5 cm and after surgery; this decreased about 40% at 24 
Fig. 1. Algorithm showing the progress of subjects through the trial phases. All patients completed the study.
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                         Variable Diclofenac(n = 18) 
Meloxicam 
(n = 18) P Value
Age (years)  22 (19-30) 23 (18-30) 0.89 
Sex (female:male) 9:9 9:9 1 
Weight (Kg)  67.18±20.60 65.21±20.46 0.77 
Duration of operation  15.92±7.42 18.067.40 0.44 
Surgical difficulty (Grade II / III / IV) 4 / 7 / 7 5 / 7 / 6 0.63 
Number of sutures  2±0.19 2.11±0.32 0.39 
Table 1. Demographic and surgical characteristics.
Data are mean ± SD, median (range), or number.
Variable
Diclofenac
(n = 18) 
Meloxicam 
(n = 18) P Value 
Time of first rescue analgesic medication 4.71±1.55 6.49±2.23 0.94 
Patients taking the first analgesic medication    
          3 h 1 1 1 
          6 h 5 7 0.72 
          9 h 6 7 1 
          12 h 7 8 1 
          24 h 7 8 1 
Number of patients requiring rescue analgesic 
procedure (sublingual ketorolac)            6          4        0.71 
Analgesic consumption (acetaminophen) 2.42±0.25 1.77±0.25 0.53 
Table 2. Comparison of analgesic efficacy of diclofenac and meloxicam.
Data are mean ± SD, or number.
Fig. 2. Pain intensity evaluated by the VAS during 24 postoperative hours (*P=0.04).
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Variable
Diclofenac
 (n = 18) 
Meloxicam 
(n = 18) P value 
Angle of the mandible and  soft-tissue pogonion  
Preoperative 11.13±0.92 11.27±0.63 0.77 
6 h 11.37±0.94 11.27±1.75 0.38 
24 h 11.88±1.30 11.37±1.93 0.35 
48 h 12.08±1.09 12.21±0.76 0.67 
72 h 11.90±0.91 12.15±0.86 0.41 
7 days 11.81±1.89 11.57±0.81 0.63 
Angle of the mandible and  outer corner of the mouth  
Preoperative 11.72±0.82 11.87±0.82 0.57 
6 h 11.83±0.62 11.96±0.74 0.58 
24 h 12.17±0.67 12.46±0.82 0.25 
48 h 12.44±0.69 12.71±0.81 0.28 
72 h 12.44±0.80 12.76±0.88 0.23 
7 days 12.01±0.55 12.11±0.88 0.68 
Angle of the mandible and lateral corner of the eye 
Preoperative 10.45±0.85 10.58±0.92 0.66 
6 h 10.65±0.81 10.76±1.27 0.75 
24 h 10.99±0.69 11.13±1.42 0.61 
48 h 11.20±0.61 11.18±1.33 0.87 
72 h 11.15±0.69 11.07±1.33 0.82 
7 days 10.77±0.83 10.76±0.95 0.95 
Angle of the mandible and tragus 
Preoperative 6.20±0.88 6.55±1.47 0.39 
6 h 6.37±0.99 6.81±1.42 0.29 
24 h 6.62±1.03 7.62±2.74 0.15 
48 h 6.71±0.94 7.39±2.53 0.29 
72 h 6.61±0.84 7.30±2.56 0.29 
7 days 6.50±0.91 6.42±0.96 0.80 
Tragus and soft-tissue pogonion 
Preoperative 15.95±0.94 15.43±2.50 0.41 
6 h 16.11±0.99 15.64±2.55 0.47 
24 h 16.41±0.99 16.13±2.64 0.67 
48 h 16.52±0.98 16.93±0.96 0.22 
72 h 16.46±0.91 16.78±1.04 0.33 
7 days 16.06±0.99 16.17±0.98 0.73 
Tragus and  outer corner of the mouth  
Preoperative 12.69±0.52 12.88±1.05 0.50 
6 h 12.85±0.49 13.08±1.03 0.39 
24 h 13.07±0.40 13.40±1.06 0.23 
48 h 13.18±0.53 13.40±0.72 0.42 
72 h 13.07±0.59 13.27±0.80 0.40 
7 days 12.95±0.55 12.88±0.71 0.60 
Tragus and lateral corner of the eye 
Preoperative 8.47±0.99 8.75±1.17 0.45 
6 h 8.76±0.58 8.90±1.16 0.65 
24 h 8.92±0.40 9.18±1.15 0.38 
48 h 9.06±0.49 9.18±0.43 0.77 
72 h 9.02±0.47 8.93±0.56 0.58 
7 days 8.90±0.67 8.69±0.42 0.26 
Table 3. Facial swelling throughout the period of evaluation.
Data are mean and SD.
Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e127-34.                                                                                                                                                 Diclofenac versus meloxicam in oral surgery
e132
hours postoperatively and, incrementing as time went 
on. Trismus scores were superior in patients who took 
meloxicam when compared with those patients receiv-
ing diclofenac (Fig. 3).
Finally, there were no complications associated with the 
surgical procedure itself, and none of the patients re-
ported adverse events associated with the medications.
Fig. 3. Evaluation of trismus (*P=0.03; and **P=0.04).
Discussion
This clinical trial evaluated the efficacy of a single 
dose of diclofenac and meloxicam administered by oral 
route for control of pain, inflammation and trismus af-
ter a mandibular third molar surgery. Duration of an-
algesia for diclofenac was in agreement with previous 
reports (16,17). However, the duration of analgesia of 
meloxicam for mandibular third molar surgery with os-
teotomy was lower compared with the sole report in the 
literature (10). A more intense pain peak was observed 
at fifth hour postoperative. Second peak of postopera-
tive pain was observed at 11 hours. It is important to 
observe that pain control was nearly similar for both 
treatment groups throughout the evaluation period ac-
cording to the VAS scores, except on the fifth hour, on 
which a statistical difference was observed in meloxi-
cam’s favor. Assessment of facial swelling employing 
the anatomical facial points was analogous for the both 
groups. It reached its peak between 48 and 72 hours af-
ter surgery. Both postoperative pain and facial swelling 
were in agreement with those previously reported in the 
literature (1). Meanwhile, trismus reached its greatest 
severity at 24 hours after surgery. Patients taking mel-
oxicam had an aperture larger than those patients re-
ceiving diclofenac. We consider that these differences 
with respect to pain intensity and mouth opening in 
meloxicam’s favor can be of clinical importance. The 
trend of data of this study could be confirmed with a 
clinical trial including a large sample of patients and a 
superior surgical difficulty comparing the analgesic, fa-
cial swelling and anti-trismus effects of meloxicam and 
diclofenac after third molar surgery. 
The practice of initiating administration of analgesic 
drugs preoperatively is particularly controversial. The 
current tendency is to start treatment at an earlier stage 
than in the past, because it has been shown that post-
operative pain can be avoided almost entirely through 
analgesic premedication (18). In our case, all surgeries 
implied a degree of osteotomy and it was assumed that 
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all patients would present postoperative pain. Medica-
tion was provided on a prophylactic basis - prior to the 
appearance of pain, and on ethical grounds.
One of the problems of evaluating the analgesic, anti-
inflammatory and anti-trismus efficacy of a drug is re-
lated to the pharmacokinetics and pharmacodynamics 
of the drugs. Another important factor to be taken into 
account is the evaluation period. In effect, with the in-
troduction of long-acting analgesics, prolonged obser-
vation periods have become necessary in the context of 
single dose studies (19).
The analgesic effect of both diclofenac and meloxicam 
has been shown in several previous clinical studies in 
comparison with others NSAID in third molar surgery. 
Diclofenac has shown a similar analgesic effect to that 
of paracetamol (20,21), ibuprofen (18,20), and ketorolac 
(22). However, aceclofenac (23), lornoxicam (24), and 
tenoxicam (25) have shown better analgesic efficacy 
than diclofenac in this type of surgery. Sener et al., 
(2005) carried out a random, single-blind study to com-
pare the analgesic efficacy of diflunisal, naproxen, mel-
oxicam, acetaminophen and rofecocixib in oral surgery. 
Nevertheless, the authors found no differences related 
with analgesic efficacy or adverse effect (9). Before our 
study and to our knowledge, meloxicam had only been 
used in comparison with NSAID in two multiple-dose 
studies on oral surgery. A clinical trial by De Menezes 
and Cury (2010) employing nimesulide 100 mg for 5 
days in comparison with meloxicam 7.5 mg twice daily 
for 5 days demonstrated an adequate and similar anal-
gesic effect of both drugs. Nonetheless, nimesulide was 
more effective than meloxicam in the control of swelling 
and trismus following third molar extraction (11). In our 
study, meloxicam was better in postoperative pain man-
agement and trismus than diclofenac. Meanwhile, our 
results on facial swelling were similar for both drugs.  
In this study no patients reported adverse effects in re-
lation to the use of these drugs. Nevertheless, clinical 
trials using diclofenac in third molar surgery have re-
ported adverse effects over the digestive and nervous 
system (20,23,24). Moreover, meloxicam has been asso-
ciated with mild adverse effects in third molar surgery. 
Sener et al., (2005) reported nausea, vomiting, bleeding 
in surgical site, allergy, and gastrointestinal symptoms 
when meloxicam was used in oral surgery (9).   
In conclusion, data of this pilot study suggest that the 
preoperative administration of a single dose of meloxi-
cam produces superior postoperative analgesia and anti-
trismus effects compared with diclofenac after mandib-
ular third molar extraction.
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